MELD-XI is predictive of mortality in venoarterial extracorporeal membrane oxygenation.
cardiogenic shock
cardiovascular research
critical care
extracorporeal membrane oxygenation
model for end-stage liver disease-excluding INR (MELD-XI)
risk stratification
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
28
4
2020
medline:
21
10
2020
entrez:
28
4
2020
Statut:
ppublish
Résumé
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving method of supporting critically ill patients. However, it is expensive and associated with high morbidity and mortality, making early predictive outcome modeling extremely valuable. The model for end-stage liver disease-excluding international normalized ratio (MELD-XI) scoring system has been shown to have prognostic value in other critically ill patient populations. A single-center retrospective review was performed for all adult patients managed on VA-ECMO from May 2011 to January 2018 (n = 247). Patients were included in the study if MELD-XI scores could be calculated during the first 48 hours on ECMO (n = 187). Receiver operating characteristic curve analysis was performed for MELD-XI in regard to in-hospital mortality. Of the 187 patients, 74 (40%) patients had MELD-XI less than 14 (low-risk) and 113 (60%) had a MELD-XI of 14 or greater (high-risk). The cohorts did not differ significantly in terms of patient characteristics or indication for ECMO. The high-risk MELD-XI group had significantly greater mortality during index hospitalization compared to the low-risk group (74% vs 39%; P < .0001). Quartile stratification demonstrated progressively worse prognosis associated with higher MELD-XI scores; the fourth quartile showed a ninefold increased risk of mortality compared to the first quartile (P < .001). The AUC for predicting index hospitalization mortality was 0.69 (95% CI, 0.62-0.77) with a Youden index (J) of 0.36 and optimized cutoff of 12.98. These findings suggest that the MELD-XI scoring system can be applied to the VA-ECMO patient population early in their course of ECMO as a prognostic tool to aid in complex clinical decision making.
Sections du résumé
BACKGROUND
BACKGROUND
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving method of supporting critically ill patients. However, it is expensive and associated with high morbidity and mortality, making early predictive outcome modeling extremely valuable. The model for end-stage liver disease-excluding international normalized ratio (MELD-XI) scoring system has been shown to have prognostic value in other critically ill patient populations.
MATERIALS AND METHODS
METHODS
A single-center retrospective review was performed for all adult patients managed on VA-ECMO from May 2011 to January 2018 (n = 247). Patients were included in the study if MELD-XI scores could be calculated during the first 48 hours on ECMO (n = 187). Receiver operating characteristic curve analysis was performed for MELD-XI in regard to in-hospital mortality.
RESULTS
RESULTS
Of the 187 patients, 74 (40%) patients had MELD-XI less than 14 (low-risk) and 113 (60%) had a MELD-XI of 14 or greater (high-risk). The cohorts did not differ significantly in terms of patient characteristics or indication for ECMO. The high-risk MELD-XI group had significantly greater mortality during index hospitalization compared to the low-risk group (74% vs 39%; P < .0001). Quartile stratification demonstrated progressively worse prognosis associated with higher MELD-XI scores; the fourth quartile showed a ninefold increased risk of mortality compared to the first quartile (P < .001). The AUC for predicting index hospitalization mortality was 0.69 (95% CI, 0.62-0.77) with a Youden index (J) of 0.36 and optimized cutoff of 12.98.
CONCLUSIONS
CONCLUSIONS
These findings suggest that the MELD-XI scoring system can be applied to the VA-ECMO patient population early in their course of ECMO as a prognostic tool to aid in complex clinical decision making.
Substances chimiques
GTP Phosphohydrolases
EC 3.6.1.-
Gm12185 protein, mouse
EC 3.6.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1275-1282Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Baran DA. Extracorporeal membrane oxygenation (ECMO) and the critical cardiac patient. Curr Transplant Rep. 2017;4(3):218-225.
Abrams D, Combes A, Brodie D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol. 2014;63(25 pt A):2769-2778.
Ghodsizad A, Koerner MM, Brehm CE, El-Banayosy A. The role of extracorporeal membrane oxygenation circulatory support in the 'crash and burn' patient: from implantation to weaning. Curr Opin Cardiol. 2014;29(3):275-280.
Rozencwajg S, Fraser J, Montero S, Combes A, Schmidt M. To be or not to be on ECMO: can survival prediction models solve the question? Crit Care Resusc. 2017;19(suppl 1):21-28.
Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246-2256.
Peigh G, Cavarocchi N, Keith SW, Hirose H. Simple new risk score model for adult cardiac extracorporeal membrane oxygenation: simple cardiac ECMO score. J Surg Res. 2015;198(2):273-279.
Chen WC, Huang KY, Yao CW, et al. The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department. Crit Care. 2016;20(1):336.
Muller G, Flecher E, Lebreton G, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med. 2016;42(3):370-378.
Wengenmayer T, Duerschmied D, Graf E, et al. Development and validation of a prognostic model for survival in patients treated with venoarterial extracorporeal membrane oxygenation: the PREDICT VA-ECMO score. Eur Heart J Acute Cardiovasc Care. 2018;8:350-359. https://doi.org/10.1177/2048872618789052
Heuman DM, Mihas AA, Habib A, et al. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13(1):30-37.
Biegus J, Zymliński R, Sokolski M, et al. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure. Eur J Heart Fail. 2016;18(12):1518-1521.
Abe S, Yoshihisa A, Takiguchi M, et al. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure. PLoS One. 2014;9(6):e100618.
Adams ED, Jackson NJ, Young T, DePasquale EC, Reardon LC. Prognostic utility of MELD-XI in adult congenital heart disease patients undergoing cardiac transplantation. Clin Transplant. 2018;32(6):e13257.
Szygula-Jurkiewicz B, Zakliczynski M, Szczurek W, Nadziakiewicz P, Gasior M, Zembala M. Predictive value of the model for end-stage liver disease score excluding international normalized ratio one year after orthotopic heart transplantation. Transplant Proc. 2016;48(5):1703-1707.
Deo SV, Al-Kindi SG, Altarabsheh SE, et al. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing. J Heart Lung Transplant. 2016;35(2):222-227.
Grimm JC, Magruder JT, Do N, et al. Modified model for end-stage liver disease excluding INR (MELD-XI) score predicts early death after pediatric heart transplantation. Ann Thorac Surg. 2016;101(2):730-735.
Grimm JC, Shah AS, Magruder JT, et al. MELD-XI score predicts early mortality in patients after heart transplantation. Ann Thorac Surg. 2015;100(5):1737-1743.
Gupta S, Cogswell RJ, Roy SS, et al. Impact of 30 day readmission after left ventricular assist device implantation. ASAIO J. 2018;65:252-256.
Critsinelis A, Kurihara C, Volkovicher N, et al. Model of end-stage liver disease-excluding international normalized ratio (MELD-XI) scoring system to predict outcomes in patients who undergo left ventricular assist device implantation. Ann Thorac Surg. 2018;106(2):513-519.
Yang JA, Kato TS, Shulman BP, et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the model of end-stage liver disease (MELD) and MELD excluding INR (MELD-XI) scoring system. J Heart Lung Transplant. 2012;31(6):601-610.
Chen Y, Liu YX, Seto WK, et al. Prognostic value of hepatorenal function by modified model for end-stage liver disease (MELD) score in patients undergoing tricuspid annuloplasty. J Am Heart Assoc. 2018;7(14):e009020.
He P, Wei X, Luo S, et al. Risk prediction in infective endocarditis by modified MELD-XI score. Eur J Clin Microbiol Infect Dis. 2018;37(7):1243-1250.
Arai T, Yashima F, Yanagisawa R, et al. Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation. Int J Cardiol. 2017;228:648-653.
Murata M, Kato TS, Kuwaki K, Yamamoto T, Dohi S, Amano A. Preoperative hepatic dysfunction could predict postoperative mortality and morbidity in patients undergoing cardiac surgery: utilization of the MELD scoring system. Int J Cardiol. 2016;203:682-689.
Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99(7):491-496.
Fukuhara S, Takeda K, Kurlansky PA, Naka Y, Takayama H. Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults. J Thorac Cardiovasc Surg. 2018;155(4):1607-1618.e6.
Wood KL, Ayers B, Gosev I, et al. Venoarterial ECMO without routine systemic anticoagulation decreases adverse events. Ann Thorac Surg. 2019:S0003-4975(19)31429-8. https://doi.org/10.1016/j.athoracsur.2019.08.040
Sern Lim H. Baseline MELD-XI score and outcome from veno-arterial extracorporeal membrane oxygenation support for acute decompensated heart failure. Eur Heart J Acute Cardiovasc Care. 2016;5(7):82-88.
Ortiz-Bautista C, García-Cosio MD, Lora-Pablos D, et al. Predicting short- and long-term outcomes in adult heart transplantation: clinical utility of MELD-XI score. Transplant Proc. 2018;50(10):3710-3714.
Nadziakiewicz P, Szyguła-Jurkiewicz B, Pacholewicz J, et al. Predictive value of models for end-stage liver disease score in patients with pulsatile flow POLVAD MEV left ventricular assist device support. Transplant Proc. 2018;50(7):2075-2079.
Prasad A, Brehm CE, Goldenberg M, et al. Early prediction of transition to durable mechanical circulatory support in patients undergoing peripheral veno-arterial extracorporeal membrane oxygenation for critical cardiogenic shock. Artif Organs. 2020;44(4):402-410.
Bonizzoli M, Lazzeri C, Cianchi G, et al. Serial lactate measurements as a prognostic tool in venovenous extracorporeal membrane oxygenation support. Ann Thorac Surg. 2017;103(3):812-818.